Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving transferase
Reexamination Certificate
2008-05-06
2008-05-06
Swope, Sheridan (Department: 1652)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving transferase
C435S029000, C435S069100
Reexamination Certificate
active
07368257
ABSTRACT:
The present invention provides compositions and methods for modulating lymphocyte activation. Nucleic acids encoding proteins and proteins so encoded which are capable of modulating lymphocyte activation are provided. Compositions and methods for the treatment of disorders related to lymphocyte dysfunction or dysregulation are also provided. Prophylactics and methods for the prevention of such disorders are also provided. Also provided are compositions and methods for diagnostic and prognostic determination of such disorders. Further provided are assays for the identification of bioactive agents capable of modulating lymphocyte activation.
REFERENCES:
Macian F., NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. Jun. 2005;5(6):472-84. Review.
Chen et al, Role of NFATx (NFAT4/NFATc3) in expression of immunoregulatory genes in murine peripheral CD4+ T cells. J Immunol. Mar. 15, 2003;170(6):3109-17.
Galye et al, Identification of regions in interleukin-1 alpha important for activity. J Biol Chem. Oct. 15, 1993;268(29):22105-11.
Whisstock et al, Prediction of protein function from protein sequence and structure. Q Rev Biophys. Aug. 2003;36(3):307-40. Review.
Han et al, Identification and characterization of a predominant isoform of human MKK3. FEBS Lett. Feb. 10, 1997;403(1):19-22.
Lu et al, Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J. Apr. 1, 1999;18(7):1845-57.
Moriguchi et al, Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and H2O2. J Biol Chem. Oct. 25, 1996;271(43):26981-8.
Fu Alan C.
Liao X. Charlene
Mancebo Helena
Wu Jun
Klarquist & Sparkman, LLP
Rigel Pharmaceuticals, Incorporated
Swope Sheridan
LandOfFree
Modulators of lymphocyte activation, Mkk3b compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of lymphocyte activation, Mkk3b compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of lymphocyte activation, Mkk3b compositions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2759430